TRDA

ENTRADA THERAPEUTICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

ENTRADA THERAPEUTICS INC (TRDA) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$47.48M; the largest are Baker Bros. Advisors, Izzy Englander, Ken Griffin. This quarter: 1 new, 2 added, 1 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Heating up

Common-stock holders5

Congress trades0

Price$6.26vs quarter-end-14.95%

Sectors0

This quarter's moves

New1

Added2

Trimmed / sold1

Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $37.34M0.2% of portfolio5,072,7302026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$37.34M	5,072,730	0.2%	Hold

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.